Fetzima FDA Approval History
FDA Approved: Yes (First approved July 25, 2013)
Brand name: Fetzima
Generic name: levomilnacipran
Dosage form: Extended-Release Capsules
Company: Allergan plc
Treatment for: Depression
Fetzima (levomilnacipran) is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of major depressive disorder.
Development timeline for Fetzima
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.